Dairylac’s postbiotic feed supplement XPM, formulated from Saccharomyces cerevisiae, has officially entered the U.S. dairy and beef markets, offering a science-backed solution to boost productivity and sustainability.
Dairylac (Pvt) ltd, one of the leaders in animal nutrition solutions, has launched its cutting-edge feed supplement in the U.S. market. XPM, postbiotic metabolite derived from saccharomyces cerevisiae is readily available in stock, is designed to enhance animal health, productivity, and sustainability, the company explains.
With proven benefits such as e.g., optimize gut microbiome, improved digestion, stabilize pH, higher milk yield, better weight gain, Dairylac states that this supplement is set to revolutionize feed efficiency in the dairy and beef production systems. It is beneficial for wide range of animals including ruminants, monogastric, equines, poultry, aquaculture, cats and dogs.
GLOBAL EXPANSION PLANS
As part of its strategic growth, Dairylac highlights it is actively seeking distributors and partners in key markets to bring this innovation to farmers worldwide.
“We’re excited to introduce this scientifically backed solution to the U.S. and are eager to collaborate with industry stakeholders in US and beyond,” said Kashaf Qasim, Global Sales Executive at Dairylac.
